Literature DB >> 6326708

Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.

S J Barteling, R Woortmeyer.   

Abstract

The inactivation of foot-and-mouth disease virus by formaldehyde was studied under different conditions, both as free virus and (as in routine vaccine production) after adsorption of the virus to aluminium hydroxide gel (alhydrogel). In the latter case infectivity was monitored after elution of the virus from the gel by isopycnic ultracentrifugation of the virus-alhydrogel mixture in CsCl. By this method good virus recoveries were obtained. Adsorption of the virus to alhydrogel (without formaldehyde) did not reduce infectivity significantly. Both adsorbed and non-absorbed virus lost infectivity at a rate of about one log10 per day (at pH 8.5, 25 degrees C--no formaldehyde). Kinetics of formaldehyde inactivation of adsorbed and non-adsorbed virus were also identical, with a fast reduction in the initial phase (in case of O1 and A10-virus approximately one log10/hour). After this initial phase inactivation became linear and rather slow (for O1 and A10-virus 0.2 log10/hour). No "tailing-off" was observed. Under standard conditions (0.04 per cent formaldehyde, pH 8.5, 25 degrees C) CD-virus was inactivated approximately 1.5 times faster than O1 and A10-virus. At 4 degrees C the inactivation of the three strains continued at about one log10/day. Increased lactalbumin hydrolysate concentrations reduced the inactivation rate, especially at the formaldehyde concentration of 0.02 per cent, which was originally applied. Quaternary amines like Tris strongly inhibited formaldehyde activity. These findings might explain some data of others who observed "tailing off". Analysis of formaldehyde inactivated antigen by SDS-PAGE and electrofocusing showed that extensive cross-linking occurs especially of VP1, probably with other virus proteins but also with non-virus proteins from the medium. VP2 and VP3 are less affected. Cross-linking was enhanced when the virus had been adsorbed to alhydrogel during inactivation. Progressive cross-linking was observed during storage of the vaccine at 4 degrees C, which also indicated that inactivation continued at this temperature. These data show that formaldehyde inactivated adsorbate vaccines can be safe.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326708     DOI: 10.1007/bf01310652

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  The effect of various inactivating agents on the viral and ribonucleic acid infectivities of foot-and-mouth disease virus and on its attachment to susceptible cells.

Authors:  F BROWN; B CARTWRIGHT; D L STEWART
Journal:  J Gen Microbiol       Date:  1963-05

2.  The inactivation of foot-and-mouth disease virus by formalin.

Authors:  T WESSLEN; Z DINTER
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.

Authors:  S J Barteling; R H Meloen; F Wagenaar; A L Gielkens
Journal:  J Gen Virol       Date:  1979-05       Impact factor: 3.891

4.  Research on foot-and-mouth disease. III. The cultivation of the virus on a practical scale in explantations of bovine tongue epithelium.

Authors:  H S FRENKEL
Journal:  Am J Vet Res       Date:  1951-07       Impact factor: 1.156

5.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

6.  The use of frozen cells in the agar-cell suspension titration technique. A reproducible system. Brief report.

Authors:  S J Barteling
Journal:  Arch Gesamte Virusforsch       Date:  1972

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  The positively charged structural virus protein (VP1) of foot-and-mouth disease virus (type O1) contains a highly basic part which may be involved in early virus-cell interaction.

Authors:  S J Barteling; F Wagenaar; A L Gielkens
Journal:  J Gen Virol       Date:  1982-10       Impact factor: 3.891

9.  Innocuity testing of foot-and-mouth disease vaccines. I. Formaldehyde-inactivated alhydrogel vaccines.

Authors:  S J Barteling; R Woortmeyer; N Visser
Journal:  J Biol Stand       Date:  1983-10

10.  Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.

Authors:  S J Barteling
Journal:  J Biol Stand       Date:  1983-10
View more
  8 in total

1.  Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model.

Authors:  Emerson de Castro Barbosa; Adriana de Souza Andrade; Myrian Morato Duarte; Gilson Faria; Felipe Campos de Melo Iani; Ana Caroline Zampiroli Ataide; Lucas Maciel Cunha; Clara Guerra Duarte; Sílvia Ligorio Fialho; Sérgio Caldas
Journal:  Mol Immunol       Date:  2022-05-23       Impact factor: 4.174

Review 2.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

3.  Evaluation of virus inactivation by formaldehyde to enhance biosafety of diagnostic electron microscopy.

Authors:  Lars Möller; Livia Schünadel; Andreas Nitsche; Ingeborg Schwebke; Manuela Hanisch; Michael Laue
Journal:  Viruses       Date:  2015-02-10       Impact factor: 5.048

4.  Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods.

Authors:  Safy El Din Mahdy; Amr Ismail Hassanin; Wael Mossad Gamal El-Din; Ehab El-Sayed Ibrahim; Hiam Mohamed Fakhry
Journal:  Vet World       Date:  2015-09-19

Review 5.  Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.

Authors:  H G Bahnemann
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

6.  Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.

Authors:  Shengnan Zhang; Meng Hao; Na Feng; Hongli Jin; Feihu Yan; Hang Chi; Hualei Wang; Qiuxue Han; Jianzhong Wang; Gary Wong; Bo Liu; Jun Wu; Yuhai Bi; Tiecheng Wang; Weiyang Sun; Yuwei Gao; Songtao Yang; Yongkun Zhao; Xianzhu Xia
Journal:  Viruses       Date:  2019-10-08       Impact factor: 5.048

7.  Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice.

Authors:  Shengnan Zhang; Feihu Yan; Dongping Liu; Entao Li; Na Feng; Shengnan Xu; Hualei Wang; Yuwei Gao; Songtao Yang; Yongkun Zhao; Xianzhu Xia
Journal:  Front Microbiol       Date:  2022-03-17       Impact factor: 5.640

Review 8.  Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study.

Authors:  Moataz Alhaj
Journal:  J Immunol Res       Date:  2016-09-04       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.